NIH R34 Grants — Planning Grant

Recent R34 awards from NIH RePORTER

Examples of funded R34 projects across the last two fiscal years. The matching-award count comes from the full result set; funding totals, averages, rankings, and examples use the first 500 records returned by NIH RePORTER. Figures reflect a snapshot last refreshed on September 5, 2026.

Example R34 projects from the sample

• Establishing a Ground Truth for Inter-Areal Neuronal Communication

  5R34NS143713-02
  Alexander Huk · UNIVERSITY OF CALIFORNIA LOS ANGELES, CA · $324,765 · awarded Aug 27, 2026 · NIH

  PROJECT SUMMARY/ABSTRACT This proposal focuses on the development of a powerful neural recording approach that leverages recent technical and conceptual innovations in neuroscience— and could take them to the next level for answering how neurons perform “computations” upon their inputs. Specifically, we propose to develop techniques for performing dual in…

• Addressing mental health and HIV medication adherence among high-risk men in a resource-limited setting

  5R34MH135806-03
  DON OPERARIO · EMORY UNIVERSITY, GA · $72,449 · awarded Aug 27, 2026 · NIH

  This R34 application, submitted under PAR-23-060 (“Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes”), proposes to develop and pilot test WeCare—a novel, integrated intervention addressing the dual and interconnected challenges of mental health and HIV medication adherence among high-risk men in…

• Implementation and pilot testing of a culturally centered CBT protocol for suicidal behaviors among youth

  5R34MH136224-03
  Yovanska DuarteVelez · EMMA PENDLETON BRADLEY HOSPITAL, RI · $112,004 · awarded Aug 26, 2026 · NIH

  Suicide attempts and suicide-related morbidity among Hispanic adolescents remain a significant and measurable mental health disparity in the United States. Hispanic/Latino youth experience elevated risk for suicidal ideation and suicide attempts, yet there remains a critical need for replicated, culturally responsive, suicide-specific interventions that can…

• Antihypertensive self-titration to improve US blood pressure control

  5R34HL178960-02
  Nancy Haff · BRIGHAM AND WOMEN'S HOSPITAL, MA · $263,576 · awarded Aug 26, 2026 · NIH

  Nearly 1 in 2 US adults has hypertension, and it is a leading cause of myocardial infarction, stroke, and death. Despite the importance of hypertension and the widespread availability of medication treatment, less than half of patients have blood pressures that are controlled. This is in part due to the way in which we deliver care, and new strategies are…

• Innovations for peer-delivered and family-engaged brief interventions for youth suicide in Nepal: A pilot hybrid type 2 implementation study

  3R34MH136250-03S2
  Ashley Hagaman · YALE UNIVERSITY, CT · $11,904 · awarded Aug 25, 2026 · NIH

  Our proposal aims to co-design and pilot test the implementation of a package of brief, theory-driven interventions for suicide prevention among youth (12–24 years) delivered by peers (YPF-SuPP). YPF-SuPP integrates two evidence-based interventions tested in South Asia (safety planning and contact follow-up) with two core innovations: safety plans delivered…

• AI-Enhanced App-based Intervention for Adolescent E-cigarette Cessation

  5R34CA287720-03
  Eunhee Park · STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY · $243,403 · awarded Aug 25, 2026 · NIH

  Project Summary Abstract Electronic cigarette (e-cigarette) use among adolescents is an emerging public health problem. In 2020, 19.5% of high school students and 4.7% of middle school students used e-cigarettes, even though e-cigarette use is known to be harmful to adolescent health, resulting in nicotine-related symptoms of addiction and various other…

• Developing measures to improve access to integrated mental health care services in under-resourced settings

  5R34MH137223-03
  Maria Prom de Illanes · BOSTON MEDICAL CENTER, MA · $179,308 · awarded Aug 25, 2026 · NIH

  Mental disorders are a leading cause of morbidity and mortality, and yet there are significant gaps in accessing mental health care in under-resourced settings. It is necessary to demonstrate acceptance, feasibility, and efficacy of mental health care systems interventions prior to larger scale-up where resources are limited, as well as ongoing measurement…

• Optimizing implementation strategies for guideline-concordant hypertensive disorders of pregnancy care in community clinics

  1R34HL186380-01
  Bridgette Blebu · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, CA · $161,500 · awarded Aug 24, 2026 · NIH

  ABSTRACT Background: Hypertensive disorders of pregnancy (HDP), including preeclampsia, occur in 10% of pregnancies in the U.S. and contribute to maternal deaths. Preeclampsia is linked to long-term cardiovascular risk, making prevention a clinical and public health priority. Daily low-dose aspirin (LDA, 81 mg daily) in pregnancy is an effective,…

• Adapting a novel mental health prevention intervention for in-transit mothers with young children

  3R34MH134047-01S1
  Shira Goldenberg · SAN DIEGO STATE UNIVERSITY, CA · $224,318 · awarded Aug 24, 2026 · NIH

  The goal of this pilot study is to adapt and pilot-test a novel mental health prevention intervention for in-transit mothers with young children (MMC). Population mobility is rising at record-high rates, with the number of women traveling with children continuing to rise. The city of Tijuana, Mexico is located at the busiest land crossing globally and faces…

• EPIC-LT: Eliminating PGD through Inhibition of CCR5 in Lung Transplantation

  5R34HL177405-02
  Daniel Calabrese · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA · $246,725 · awarded Aug 21, 2026 · NIH

  Project Summary Lung transplant recipient survival lags other solid organ recipients, with the main early causes of death being primary graft dysfunction (PGD). PGD occurs in up to 1/3 of all recipients, is driven by the innate immune response, and has no known medical therapies for treatment or prevention. Our group has recently shown that Natural Killer…

• Planning grant to evaluate the use of pentavalent meningococcal vaccine in pregnant women in sub-Saharan Africa

  1R34AI195140-01
  Wilbur Chen · UNIVERSITY OF MARYLAND BALTIMORE, MD · $233,250 · awarded Aug 20, 2026 · NIH

  Project Summary/Abstract Meningococcal disease in sub-Saharan Africa is an annually recurring and devastating public health problem. Building upon what has been observed to be the near elimination of serogroup A disease with the development and implementation of a monovalent meningococcal vaccine, MenAfriVac, a pentavalent meningococcal vaccine was…

• Innovations for peer-delivered and family-engaged brief interventions for youth suicide in Nepal: A pilot hybrid type 2 implementation study

  3R34MH136250-03S1
  Ashley Hagaman · YALE UNIVERSITY, CT · $37,495 · awarded Aug 20, 2026 · NIH

  Our proposal aims to co-design and pilot test the implementation of a package of brief, theory-driven interventions for suicide prevention among youth (12–24 years) delivered by peers (YPF-SuPP). YPF-SuPP integrates two evidence-based interventions tested in South Asia (safety planning and contact follow-up) with two core innovations: safety plans delivered…

Compare nearby NIH grant mechanisms

Searchers often land on R34 while deciding between adjacent NIH activity codes. Compare scope, NIH staff involvement, budget scale, and applicant stage before choosing a funding opportunity.

Open NIH NOFOs for R34

NIH accepts R34 applications only through a notice of funding opportunity (NOFO). These 13 are open or opening soon; each page lists due dates, participating institutes, related notices, and the projects NIH funded under it.